Access to medicine for skin conditions
IN 2024, the NSW Government’s pharmacy prescribing trial will make it easier for people with specific skin conditions to access prescription medicines. The trial allows authorised pharmacists to supply certain medicines after a consultation, aiming to ease pressure on primary care settings. The next phase includes treatments for impetigo and shingles, addressing dermatitis and mild plaque psoriasis. The trial, expanding to over 1,100 pharmacies, initially focused on uncomplicated urinary tract infections and the oral contraceptive pill, benefiting over 6,000 women. The skin condition treatment component will run for 12 months, enhancing timely access to care.






